Johns Hopkins to establish new RNA innovation center in collaboration with TriLink BioTechnologies
The center, anchored in the Institute for NanoBioTechnology, will speed the cycle of RNA innovation in pursuit of advanced therapies
Stay updated with breaking news from Jeff Coller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The center, anchored in the Institute for NanoBioTechnology, will speed the cycle of RNA innovation in pursuit of advanced therapies
Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.
/PRNewswire/ -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research...
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based therapies for severe genetic diseases, today announced the appointment of leading tRNA scientist...
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced an agreement to exclusively license "mRNA...